Wednesday, October 29, 2014 11:43:54 AM
At a minimum, the press release has been covered with stories in the Washington Post Innovation blog, The Warren Tribune Chronicle, Warren, Ohio; The YoungstownCBS/Fox/ABC/NBC Youngstown, Ohio affiliated television stations; NBC/Pittsburgh, Fox/Tampa television.
As a result, NanoLogix N-Assay (V) is currently being evaluated by pharmaceutical companies for use as a simple rapid diagnostic tool for viruses for use in remote locations in close proximity to outbreak events. Nanologix this week signed two Mutual Confidentiality Agreements with US corporations interested in their technology.
Given the key word "Confidentiality", further information will be released when and if dictated by events.
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM